salvia tomentosa/krabbamein

Krækjan er vistuð á klemmuspjaldið

Veldu tegund tegund

14 niðurstöður

Immunoassay and Regulation of Traditional Chinese Medicine on Cancer Patients

Aðeins skráðir notendur geta þýtt greinar

Skráðu þig / skráðu þig

Traditional Chinese medicine (TCM) and dendritic cells (DCs) activation/maturation One of the important approaches to successful cancer immunotherapy is generation of specific T cell responses by dendritic cells (DCs). DCs are the most potent antigen-presenting cells for naive T cells, because their

A Study of Sequential Anlotinib Followed by EP Regimen Plus Concurrent Radiotherapy for Unresectable Stage III Non-small Cell Lung Cancer

Aðeins skráðir notendur geta þýtt greinar

Skráðu þig / skráðu þig

Anlotinib After Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer（ALTER-L029）

Aðeins skráðir notendur geta þýtt greinar

Skráðu þig / skráðu þig

Anlotinib (AL3818) is a kind of innovative medicines approved by State Food and Drug Administration（SFDA:2011L00661） which was researched by Jiangsu Chia-tai Tianqing Pharmaceutical Co., Ltd. Anlotinib is a kinase inhibitor of receptor tyrosine with multi-targets, especially for

Study of Anlotinib Combined With Icotinib as the First-line Treatment in Patients With EGFR Mutation-positive NSCLC

Aðeins skráðir notendur geta þýtt greinar

Skráðu þig / skráðu þig

Anlotinib Hydrochloride is a kind of innovative medicines approved by State Food and Drug Administration（CFDA:2011L00661） which was developed by Jiangsu Chia-tai Tianqing Pharmaceutical Co., Ltd. Anlotinib is a kinase inhibitor of receptor tyrosine with multi-targets, especially for

Anlotinib Plus Chemotherapy for Patients With Advanced Non-small Cell Lung Cancer

Aðeins skráðir notendur geta þýtt greinar

Skráðu þig / skráðu þig

Study on the Optimal Strategy for Acute-on-chronic Liver Failure With Integrative Treatment

Aðeins skráðir notendur geta þýtt greinar

Skráðu þig / skráðu þig

Study design This prospective, multi-center, parallel, centrally randomized controlled trial was designed in accordance with the Consolidated Standards of Reporting Trials (CONSORT) and Standard Protocol Items: Recommendations for Interventional Trials (SPIRIT) guidelines, which is led by the

Clinical Studies by Using Alphacait to Screen Drugs for Advanced Solid Tumor

Aðeins skráðir notendur geta þýtt greinar

Skráðu þig / skráðu þig

Tumor heterogeneity leads to a significant difference in the rate of response to drugs in patients with the same pathological type. According to the information, the current initial effective rate of domestic and foreign chemotherapeutic single drug is no more than 30%, even if treated with repeated

Study of Anlotinib in Patients With Advanced Non-small Cell Lung Cancer（ALTER0303）

Aðeins skráðir notendur geta þýtt greinar

Skráðu þig / skráðu þig

Study of Anlotinib in Patients With Metastatic Colorectal Cancer（mCRC）(ALTER0703)

Aðeins skráðir notendur geta þýtt greinar

Skráðu þig / skráðu þig

Anlotibib (AL3818) is a kind of innovative medicines approved by State Food and Drug Administration（SFDA:2011L00661） which was researched by Jiangsu Chia-tai Tianqing Pharmaceutical Co., Ltd.To compare the effects and safety of Anlotinib with placebo in patients with metastatic colorectal cancer

A Prospective Control Study of Cidan Capsule Combined With TACE in Hepatocellular Carcinoma

Aðeins skráðir notendur geta þýtt greinar

Skráðu þig / skráðu þig

Hepatocellular carcinoma (HCC) is one of the most common malignances seen in different regions of the world. Surgical resection provides the best chance of cure for selected patients. However, we have long been perplexed by high rates of tumor recurrence, which is often the main cause of long-term

Phase II Study of Anlotinib in Patients With Advanced Non-small Cell Lung Cancer（ALTER0302）

Aðeins skráðir notendur geta þýtt greinar

Skráðu þig / skráðu þig

An Open-label, Phase I/IIa, Dose Escalating Study of 2B3-101 in Patients With Solid Tumors and Brain Metastases or Recurrent Malignant Glioma.

Aðeins skráðir notendur geta þýtt greinar

Skráðu þig / skráðu þig

This is a Phase I/IIa, multicenter, open-label, dose-escalation study. The study will be conducted in 6 phases: "2B3-101 single agent dose-escalation phase", "a 2B3-101 with trastuzumab dose-escalation phase", "a Breast cancer brain metastases study-expansion phase","a Recurrent malignant glioma

Cisplatin Based Chemoradiation v.s Radiotherapy for Cervical Cancer and With Clinically Defined Good Prognosis

Aðeins skráðir notendur geta þýtt greinar

Skráðu þig / skráðu þig

OBJECTIVES: Primary Objectives: •To examine if low-risk, as defined by clinical and radiological parameters, stage IB-IIB cervical cancer patients treated by cisplatin-based CCRT have greater toxicities but similar survival rate as those treated by RT alone. Secondary Objectives: •To conduct a

Development of Active Safety Surveillance System for Traditional Chinese Medicine

Aðeins skráðir notendur geta þýtt greinar

Skráðu þig / skráðu þig

Skráðu þig á
facebook síðu okkar

Herbal & Natural Medicine

Heillasta gagnagrunnur lækningajurtanna sem studdur er af vísindum

Virkar á 55 tungumálum
Jurtalækningar studdir af vísindum
Jurtaviðurkenning eftir ímynd
Gagnvirkt GPS kort - merktu jurtir á staðsetningu (kemur fljótlega)
Lestu vísindarit sem tengjast leit þinni
Leitaðu að lækningajurtum eftir áhrifum þeirra
Skipuleggðu áhugamál þitt og vertu vakandi með fréttarannsóknum, klínískum rannsóknum og einkaleyfum

Sláðu inn einkenni eða sjúkdóm og lestu um jurtir sem gætu hjálpað, sláðu jurt og sjáðu sjúkdóma og einkenni sem hún er notuð við.
* Allar upplýsingar eru byggðar á birtum vísindarannsóknum